Zhuang, Qingyuan
Zhang, Alwin Yaoxian
Cong, Ryan Shea Tan Ying
Yang, Grace Meijuan
Neo, Patricia Soek Hui
Tan, Daniel SW
Chua, Melvin LK
Tan, Iain Beehuat
Wong, Fuh Yong
Eng Hock Ong, Marcus
Shao Wei Lam, Sean
Liu, Nan
Funding for this research was provided by:
National Medical Research Council (Research Training Fellowship)
Lien Centre for Palliative Care (LCPC-EX20-0003)
Article History
Received: 26 July 2023
Accepted: 15 May 2024
First Online: 20 May 2024
Declarations
:
: The project was reviewed by the SingHealth Centralised Institutional Review Board (CIRB 2021/2041) and exempted from further ethical deliberation as it involved the use of de-identified datasets, which does not meet the definition of Human Subject Research. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Qingyuan Zhuang, Alwin Zhang, Grace Yang, Patricia Neo, Daniel Tan, Fuh Yong Wong, Marcus Ong, Sean Lam, Liu Nan.
: Melvin L.K. Chua reports personal fees from Astellas, Janssen, Bayer, Pfizer, BeiGene, MSD, Varian, IQVIA, Telix Pharmaceuticals, personal fees and non-financial support from AstraZeneca, non-financial support from Decipher Biosciences, non-financial support from MedLever, consults for immunoSCAPE Inc., and is a co-inventor of the patent of a High Sensitivity Lateral Flow Immunoassay For Detection of Analyte in Sample (10202107837T), Singapore and serves on the Board of Directors of Digital Life Line Pte Ltd that owns the licensing agreement of the patent, outside the submitted work. All other authors declare no competing interests.